A provider can help develop a plan for tapering or transitioning off the medication if needed
According to the authors, the funders had no role in the study's design, data collection, analysis, interpretation, manuscript preparation, review, approval, or publication decisions
Interactions of the circadian CLOCK system and the HPA axis
Prideaux L, Kamm MA, De Cruz PP, Chan FKL, Ng SC
NIH Office Of Dietary Supplements
Key Takeaways Starting dose: 2mg once weekly for the first 4 weeks to assess tolerance Titration schedule: Increase every 4 weeks: 2mg 4mg 8mg 12mg (max) Half-life: Approximately 6 days, reaching steady state in 4-5 weeks Injection frequency: Once weekly on the same day each week Microdosing option: Some users split doses for improved tolerability Investigational Drug: Retatrutide is NOT FDA-approved and is currently only available through clinical trials